News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wijngaard Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/20/2021 |
4
| Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.7, valued at
$340k
|
|
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $1.91, valued at
$38.2k
|
|
| 08/21/2020 |
4
| Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.72, valued at
$111.6k
|
|
| 06/25/2020 |
4
| Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $2.73, valued at
$81.9k
|
|
| 06/25/2020 |
3
| Wijngaard Peter (Director) has filed a Form 3 on Hepion Pharmaceuticals, Inc. |
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| Wijngaard Peter (Chief Development Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 491 shares
@ $21.6, valued at
$10.6k
|
|
| 06/10/2019 |
3/A
| Wijngaard Peter (Chief Development Officer) has filed a Form 3/A on MEDICINES CO /DE |
| 06/07/2019 |
3
| Wijngaard Peter (Chief Development Officer) has filed a Form 3 on MEDICINES CO /DE |
|
|